#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinoblastoma Cervix carcinoma Haemophilia Chronic lymphocytic leukaemia refractory Alveolar proteinosis Staphylococcal infection Glycogen storage disease type I Acquired haemophilia Hepatitis B Paroxysmal nocturnal haemoglobinuria Rhabdomyosarcoma Immune-mediated enterocolitis Neurodermatitis Malignant neoplasm of choroid Infantile spasms More trials…

    Learn about Rare Diseases

    Leukoencephalopathy – Diagnostics Choroid melanoma – Trials in Disease Tuberous sclerosis complex – Diagnostics Antisynthetase syndrome – Life with Disease Medulloblastoma recurrent – Trials in Disease Pituitary-dependent Cushing’s syndrome Myelodysplastic syndrome – Treatment Gaucher’s disease type I – Basic Information Lymphangiosarcoma – Life with Disease Wiskott-Aldrich syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Glycerol Aminohippuric Acid Prucalopride Nido-361 Ambrosia Artemisiifolia (302) Acenocoumarol Depemokimab ABY-271 Prednisone Acetate DROSPIRENONE Mometasone Furoate Ph. Eur. Ripasudil Sildenafil Citrate FLUORIDE Metoprolol Succinate Eftrenonacog Alfa Levoleucovorin MRNA-1345 Idarubicin Cldn6 Car-T(A) More therapies…

    Learn about Your Condition

    Low cardiac output syndrome Myositis Renal cancer Biliary tract disorder Bronchitis Basal cell carcinoma Thyroidectomy Fibromyalgia Neuromyopathy Infantile spasms Delirium Cartilage injury Angiosarcoma non-metastatic Pseudomyxoma peritonei Pruritus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Systemic lupus erythematosus

  • Study of Enpatoran in Adults with Systemic Lupus Erythematosus (SLE) and Cutaneous Lupus Erythematosus (CLE)

    Not recruiting

    2 1
    Investigated Diseases:
    • Chronic cutaneous lupus erythematosus
    • Cutaneous lupus erythematosus
    • Subacute cutaneous lupus erythematosus
    Investigated Drugs:
    • Enpatoran
    Bulgaria Greece Poland Romania Spain

  • Study on Ianalumab for Patients with Systemic Lupus Erythematosus

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Tenofovir Disoproxil
    France Germany Italy Romania

  • Study on Belimumab for Children with Systemic Lupus Erythematosus (SLE)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Belimumab
    Spain

  • Study on the Effectiveness and Safety of Afimetoran for Patients with Active Lupus

    Not recruiting

    2 1
    Investigated Drugs:
    • Afimetoran Besilate Dihydrate
    France Germany Ireland Poland Romania Spain

  • Study of PF-06823859 for Adults with Active Cutaneous or Systemic Lupus Erythematosus with Skin Symptoms

    Not recruiting

    2 1
    Investigated Diseases:
    • Cutaneous lupus erythematosus
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Humanised Igg1K Monoclonal Antibody Against Interferon Beta
    Greece Spain

  • Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Systemic Lupus Erythematosus

    Not recruiting

    2 1
    Investigated Drugs:
    • Deucravacitinib
    Hungary Poland Romania Spain
Previous Page
1 … 6 7 8 9 10
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!